Cleared Traditional

ALT S.C.E. (GPT)

K863053 · J. D. Assoc. · Chemistry
Dec 1986
Decision
120d
Days
Class 1
Risk

About This 510(k) Submission

K863053 is an FDA 510(k) clearance for the ALT S.C.E. (GPT), a Nadh Oxidation/nad Reduction, Alt/sgpt (Class I — General Controls, product code CKA), submitted by J. D. Assoc. (Montclair, US). The FDA issued a Cleared decision on December 10, 1986, 120 days after receiving the submission on August 12, 1986. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1030.

Submission Details

510(k) Number K863053 FDA.gov
FDA Decision Cleared SESE
Date Received August 12, 1986
Decision Date December 10, 1986
Days to Decision 120 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary —

Device Classification

Product Code CKA — Nadh Oxidation/nad Reduction, Alt/sgpt
Device Class Class I — General Controls
CFR Regulation 21 CFR 862.1030

Similar Devices — CKA Nadh Oxidation/nad Reduction, Alt/sgpt

All 126
HITACHI CLINICAL ANALYZER S TEST REAGENT CARTRIDGE ALT, HITACHI CLINICAL ANALYZER S TEST REAGENT CARTRIDGE AST
K120945 · Hitachi Chemical Diagnostics, Inc. · Jun 2013
ACE ALT REAGENT
K113382 · Alfa Wassermann · Jul 2012
DIMENSION VISTA ALBUMIN, ALKALINE PHOSPHATASE, ASPARTATE AMINO TRANSFERASE, CARBAMAZEPINE & ALANINE AMINO TRANSFERASE
K061020 · Dade Behring, Inc. · May 2006
CARESIDE ALT
K020487 · Careside, Inc. · Jun 2002
ALT (GPT) LIQUID STABLE 2 VIAL - INCORPORATING DYNAMIC STABILIZATION TECHNOLOGY - (DST)
K980028 · Trace America, Inc. · Feb 1998
TRACE REAGENT LINE FOR THE COBAS MIRA
K973869 · Trace America, Inc. · Jan 1998